Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites Fluid-Reference-Cited by-同舟云学术

Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites Fluid

Published:2000-08-10 Issue:12 Volume:11 Page:1657-1669
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Blackwell Jerry L.¹,Li Hui²,Gomez-Navarro Jesus²,Dmitriev Igor³,Krasnykh Victor³,Richter Christy A.⁴,Shaw Denise R.⁵,Alvarez Ronald D.⁶,Curiel David T.³,Strong Theresa V.²

Affiliation:

1. Gene Therapy Center and Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294.

2. Gene Therapy Center and Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294.

3. Gene Therapy Center, University of Alabama at Birmingham, Birmingham, AL 35294.

4. Division of Otolaryngology, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294.

5. Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294.

6. Department of Obstetrics and Gynecology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340050111313

Reference58 articles.

1. A Phase I Study of Recombinant Adenovirus Vector-Mediated Delivery of an Anti-erbB-2 Single-Chain (sFv) Antibody Gene for Previously Treated Ovarian and Extraovarian Cancer Patients. University of Alabama at Birmingham, Birmingham, Alabama

2. HUMAN GENE MARKER/THERAPY CLINICAL PROTOCOLS (Complete Updated Listings)

3. Adenovirus-mediated gene therapy of ovarian cancer in a mouse model

4. Modern treatment options in epithelial ovarian carcinoma

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M11: A Tropism-Modified Oncolytic Adenovirus Arming with a Tumor-Homing Peptide for Advanced Ovarian Cancer Therapies;Human Gene Therapy;2022-03-01

2. Targeted Molecular Therapy for Ovarian Cancer Patients;Advances in Diagnosis and Management of Ovarian Cancer;2022

3. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer;Cancer Gene Therapy;2020-09-19

4. Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies;Clinical Cancer Research;2018-05-24

5. Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites;Molecular Therapy - Oncolytics;2017-09